Mon-Thu 8-18, Fri 8-16 (GMT +2)
Information on ongoing free drug trials that may need new subjects
Clinical drug trials aim to find better cancer treatments. Docrates Cancer Center provides an opportunity for cancer researchers, research institutions and pharmaceutical companies to perform clinical studies as part of the normal activities of the hospital. Studies are always performed under the close supervision of the relevant authorities.
Appointments with Docrates Cancer Center specialists are available without referral, which means that cancer patients from all parts of Finland have the opportunity to participate in clinical studies at Docrates. Such studies can allow participants to benefit from the newest treatments for several years before they become available at a pharmacy.
Docrates Cancer Center works actively to allow all cancer patients seeking new treatments to participate in clinical studies and receive investigational treatments if no curative treatment is available for their condition.
An oncologist at Docrates Cancer Center can, at your request, search public databases for clinical trials in any geographical area that could be suitable for you. This may be an alternative if there is no established treatment available for your cancer or condition, or if they have already been used, or if the doctor knows of a promising investigational medicinal product that is not yet available outside clinical trials. Read more.
Research Nurse Henna Lundenius tel.+358-50-500-1895/+358-10-773-2000 or by e-mail henna.lundenius(a)docrates.com.
Many cancer patients have several concerns when it comes to the coronavirus pandemic, e.g. how does the situation impact my...Read more
The coronavirus is a concern among cancer patients. We listed the most common concerns and the answers to them.Read more
Genuinely personalised cancer treatment is based on genetics and individual needs. At Docrates Cancer Center, treatment is supervised by Chief...Read more
The physicians of Docrates Cancer Center took part in a major event organised by the American Society of Clinical Oncology...Read more